UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001945
Receipt number R000002367
Scientific Title Clinical effectiveness of Donepezil Hydrochloride for radiation-induced memory disturbance in patients with brain tumor
Date of disclosure of the study information 2009/06/01
Last modified on 2016/05/09 16:37:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical effectiveness of Donepezil Hydrochloride for radiation-induced memory disturbance in patients with brain tumor

Acronym

Clinical effectiveness of Donepezil Hydrochloride for radiation-induced memory disturbance in patients with brain tumor

Scientific Title

Clinical effectiveness of Donepezil Hydrochloride for radiation-induced memory disturbance in patients with brain tumor

Scientific Title:Acronym

Clinical effectiveness of Donepezil Hydrochloride for radiation-induced memory disturbance in patients with brain tumor

Region

Japan


Condition

Condition

brain tumor

Classification by specialty

Radiology Neurosurgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate clinical effectiveness of Donepezil Hydrochloride to radiation-induced memory disturbance in patients with brain tumor

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2

Explanatory

Developmental phase

Phase II


Assessment

Primary outcomes

Improvement of memory disturbance

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Donepezil Hydrochloride

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. no history of radiation therapy to brain
2. expect more than 6 months survival
3. patiets with small cell lung cancer who will receive prophylactic cranial irradiation
4.patiets with multiple brain tumors, without midline shift, nor without huge tumors of more than 5cm diameter
5.patients without disease of contra-indication to Donepezil Hydrochloride

Key exclusion criteria

Patients of contra-indication to Donepezil Hydrochloride

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ryohei Sasaki

Organization

Kobe University Hospital

Division name

Division of Radiation Oncology

Zip code


Address

7-5-2 Kusunokicho Chuouku Kobe city

TEL

078-382-6104

Email

rsasaki@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yasuo Ejima

Organization

Kobe University Hospital

Division name

Division of Radiation Oncology

Zip code


Address

7-5-2 Kusunokicho Chuouku Kobe city

TEL

078-382-6104

Homepage URL


Email

ejimay@med.kobe-u.ac.jp


Sponsor or person

Institute

Department od Radiology, Kobe University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department od Radiology, Kobe University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2009 Year 05 Month 31 Day

Date of IRB


Anticipated trial start date

2009 Year 06 Month 01 Day

Last follow-up date

2017 Year 06 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 05 Month 07 Day

Last modified on

2016 Year 05 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002367


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name